SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001214659-16-013331
Filing Date
2016-08-19
Accepted
2016-08-19 17:00:27
Documents
2
Group Members
KEVIN C. TANGTANG CAPITAL MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 b819160sc13g.htm SC 13G 119500
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 15826
  Complete submission text file 0001214659-16-013331.txt   137035
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 161843675
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G